SCHEMBL8577012

SCHEMBL8577012

CC(C)C(=O)Nc1ccc(-c2n[nH]c3ncnc(Nc4cccc(Cl)c4)c23)cc1

nearest known ligand 0.53

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
EGFR P00533 16/20 0.53
SRC P12931 8/20 0.53
CDK1 P06493 11/20 0.50
ABL1 P00519 12/20 0.49
PRKCA P17252 5/20 0.49
PDGFRB P09619 2/20 0.47
MET P08581 1/20 0.47
CDK8 P49336 1/20 0.47
ROCK1 Q13464 1/20 0.47
NTRK3 Q16288 1/20 0.47
NTRK2 Q16620 1/20 0.47
AURKB Q96GD4 1/20 0.47
CLK4 Q9HAZ1 1/20 0.47
CCNB2 O95067 1/20 0.47
CCNB1 P14635 1/20 0.47
CCNB3 Q8WWL7 1/20 0.47
PDGFRA P16234 1/20 0.47
ABL2 P42684 1/20 0.47
KDR P35968 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4534076 0.89 EGFR (0.55) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8115017 0.88 EGFR (0.51) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8115115 0.87 EGFR (0.53) EGFRSRCCDK1ABL1PRKCA
SCHEMBL4531293 0.87 EGFR (0.57) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8115586 0.85 GRM4 (0.56) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8117280 0.84 EGFR (0.74) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8579664 0.83 SMN1; SMN2 (0.54) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8115158 0.83 EGFR (0.68) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8116135 0.83 EGFR (0.69) EGFRSRCCDK1ABL1PRKCA
SCHEMBL8121174 0.82 EGFR (0.52) EGFRSRCCDK1ABL1PRKCA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 WO claimed
WO-1998014449-A1 FUSED PYRAZOLE DERIVATIVES AND PROCESSES FOR THEIR PREPARATION NOVARTIS AG (CH) 1998-04-09 WO disclosed